Anal Carcinoma clinical trials

Explore recruiting anal carcinoma clinical trials.

Recruiting anal carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Anal Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

INTERACT-ION : Ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin and 5-fluorouracil) followed by chemoradiotherapy in patients with stage III squamous cell anal carcinoma. A phase II study.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

SPARTANA : Spartalizumab, mDCF (docetaxel, cisplatin and 5-fluorouracil) and radiotherapy in patients with metastatic squamous cell anal carcinoma. A Phase IIA study

France

Therapeutic exploratory (Phase II) EU CTIS Study details

RADIANCE Radiochemotherapy +/- Durvalumab for locally-advanced Anal Carcinoma; A multicenter, randomized, phase II trial of the German Anal Cancer Study Group

Austria, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Anal Carcinoma trials by city

Anal Carcinoma in Toronto Anal Carcinoma in Vancouver Anal Carcinoma in Montreal Anal Carcinoma in Calgary Anal Carcinoma in Edmonton Anal Carcinoma in Ottawa Anal Carcinoma in Winnipeg Anal Carcinoma in Quebec City Anal Carcinoma in Hamilton Anal Carcinoma in Kitchener Anal Carcinoma in London Anal Carcinoma in Halifax Anal Carcinoma in New York Anal Carcinoma in Los Angeles Anal Carcinoma in Chicago Anal Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease